ALX Oncology Holdings Inc. (ALXO) Misses Q3 EPS by 4c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Broadcom (AVGO) call put ratio 1.6 calls to 1 put into quarter results
• Wynn Resorts Ltd (WYNN) call put ratio 1 call to 1 put as share price up 2.3%
• Active options: GOOGL PLTR NFLX AMD SOFI MSFT AVGO ASTS ORCL MSTR SMCI